Search Results 1041-1050 of 19005 for Neutrophil

1. PRE-I-SPY Phase I/Ib Oncology Platform Program - Mayo Clinic

   The purpose of the study is to evaluate single agents or combinations in a metastatic treatment setting that may be relevant for breast cancer patients with the ...

2. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

   Absolute neutrophil count (ANC) < 1.0 x 10^9/L; Absolute lymphocyte count < 0.5 x 10^9/L; Platelet count < 75 x 10^9/L; Hemoglobin (Hgb) < 8 g/dL; Potassium ...

3. Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   Absolute neutrophil count (ANC) < 1x 10^9/L. Platelet count < 50 x 10^9/L. Prior Therapy; Use of inhaled prostanoids. Chronic use of oral anticoagulants ...

4. Testing Whether High Dose Chemotherapy And Infusion Of The Patients' Own Stem Cells Improves Survival In Patients With Peripheral T-cell Lymphoma Who Achieved A Complete Response At The End Of The Initial Chemotherapy - Mayo Clinic

   * Absolute neutrophil count (ANC) ≥ 1000/mcL (obtained ≤ 14 days prior to protocol randomization) * Platelets ≥ 75,000/mcL (obtained ≤ 14 days prior to ...

5. Tumor Treating Fields For The Treatment Of Leptomeningeal Metastases Of The Spine In Patients With Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) greater than 0.5 x 10^9/L. Patients must have adequate liver function, total bilirubin < 2.5 mg/dL, unless elevated total ...

6. Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelets (PLT) ≥ 100,000/mm^3; Total bilirubin ≤ 1.5 x upper normal limit (UNL); Aspartate aminotransferase ...

7. Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/mm3; Platelet count ≥100,000/mm3; Total bilirubin ≤1.5 x ULN; Alanine aminotransferase (ALT) and aspartate ...

8. Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis - Mayo Clinic

   Absolute neutrophil count < 1,000 cells/µL; Platelet count < 80,000 cells/µL; Hemoglobin < 8.0 g/dL. Subjects who have been given: Prednisone at dose of >10 mg ...

9. Pirtobrutinib And Venetoclax With MRD Detection For Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   This study also seeks to adopt a blood test which shows a small number of cancer cells in the body after cancer treatment called minimal residual disease as a ...

10. Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy - Mayo Clinic

    Absolute neutrophil count (ANC) >= 1.0 x 10^9/L; Platelet count >= 75 x 10^9/L; Hemoglobin >= 8.5 g/dL; Lymphocytes >= 0.3 x 10^9/L; Total bilirubin =< 2 x ...